Assessment of asymmetrical dimethylarginine metabolism in patients with critical illness. (20th February 2017)

• Record Type: Journal Article
• Authors: Ghashut, Rawia A.; Blackwell, Scott; Ryan, Sylvia; Willox, Laura; McMillan, Donald C.; Kinsella, John; Talwar, Dinesh
• Is Part Of: European journal of clinical investigation. Volume 47:Number 4(2017)
• Page Start: 279
• Page End: 288
• Publication Date: 2017-02-20
• Subjects: Arginine -- asymmetrical dimethylarginine -- critical illness -- homoarginine -- symmetrical dimethylarginine; Pathology -- Periodicals; Medical research -- Periodicals; 616.075
• DOI: 10.1111/eci.12710
• Languages: English
• ISSNs: 0014-2972

Abstract

Abstract: Background: Critically ill patients experience metabolic disorders including hypercatabolic state and hyperglycaemia, and these are associated with poor outcome. Hyperglycaemia and asymmetrical dimethylarginine (ADMA) are reported to have significant influences on endothelial dysfunction. The aim of this study was to examine the relationship between plasma ADMA and related arginine metabolism in patients with critical illness. Materials and methosds: Two venous blood samples (EDTA) (104 patients), on admission and follow‐up sample in the last day in intensive care unit (ICU) (died or discharge sample median 7, interquartile range (IQR) 6–8, range 5–15). Plasma ADMA, arginine, homoarginine and SDMA were measured by high‐performance liquid chromatography (HPLC). Result: ADMA ( P < 0·01) and SDMA ( P < 0·05) were elevated, and homoarginine was decreased ( P < 0·05) in nonsurvivors and was directly associated with predicted mortality rate ( P < 0·05 and P < 0·001), Sequential Organ Failure Assessment (SOFA) ( P < 0·05, P < 0·001), ICU stay ( P < 0·05, P < 0·001) and mortality ( P < 0·01, P < 0·05). ADMA was directly associated with SDMA ( P < 0·001), albumin ( P < 0·05), ICU stay and mortality ( P < 0·01). SDMA was directly associated with creatinine ( P < 0·001) and Acute physiology and Chronic Health Evaluation II score ( P < 0·001). In the follow‐up measurements, there was a significant decrease in SOFA score ( P < 0·01), homoarginine ( P < 0·01), aminotransferase ( P < 0·01), Laboratory Glucose ( P < 0·01) and albumin ( P < 0·01). In contrast, there was an increase in arginine ( P < 0·01), ADMA ( P < 0·01), ADMA:SDMA ratio ( P < 0·01) and the norepinephrine administration ( P < 0·01). Conclusion: In the present longitudinal study, ADMA metabolism was altered in patients with critical illness and was associated with disease severity and mortality.